SEC
|
Singhal Priya
|
Head of Development
|
|
-431
|
$204.22
|
-$88.02K
|
|
SEC
|
Singhal Priya
|
Head of Development
|
|
-93
|
$213.09
|
-$19.82K
|
|
SEC
|
Singhal Priya
|
Head of Development
|
|
-262
|
$221.23
|
-$57.96K
|
|
SEC
|
Singhal Priya
|
Head of Development
|
|
-108
|
$221.49
|
-$23.92K
|
|
SEC
|
Rowinsky Eric K
|
N/A
|
|
+455
|
$222.54
|
+$101.26K
|
|
SEC
|
Singhal Priya
|
Head of Development
|
|
-419
|
$239.45
|
-$100.33K
|
|
SEC
|
Biogen MA Inc.
|
N/A
|
|
-6M
|
$0.50
|
-$3.00M
|
|
SEC
|
Biogen MA Inc.
|
N/A
|
|
-500K
|
$5.31
|
-$2.66M
|
|
SEC
|
Willoughby Scott B.
|
SVP, Gen. Counsel & Secretary
|
|
-864
|
$6.33
|
-$5.47K
|
|
SEC
|
Duraibabu Prathyusha
|
Vice President, Finance
|
|
-842
|
$3.76
|
-$3.17K
|
|
SEC
|
Markels John
|
N/A
|
|
+6.8K
|
$3.69
|
+$25.03K
|
|
SEC
|
PARKER H STEWART
|
N/A
|
|
+5K
|
$3.60
|
+$18.00K
|
|
SEC
|
Willoughby Scott B.
|
SVP, Gen. Counsel & Secretary
|
|
-140
|
$4.15
|
-$581.00
|
|
SEC
|
Willoughby Scott B.
|
SVP, Gen. Counsel & Secretary
|
|
-4K
|
$4.70
|
-$18.69K
|
|
SEC
|
Duraibabu Prathyusha
|
Vice President, Finance
|
|
-345
|
$5.75
|
-$1.98K
|
|
SEC
|
Biogen MA Inc.
|
N/A
|
|
-2.8K
|
$8.51
|
-$23.52K
|
|
SEC
|
Biogen MA Inc.
|
N/A
|
|
-82K
|
$8.55
|
-$699.28K
|
|
SEC
|
Biogen MA Inc.
|
N/A
|
|
-24K
|
$8.56
|
-$202.53K
|
|
SEC
|
Biogen MA Inc.
|
N/A
|
|
-128K
|
$8.59
|
-$1.10M
|
|
SEC
|
Biogen MA Inc.
|
N/A
|
|
-2.6K
|
$8.51
|
-$22.16K
|
|
SEC
|
Biogen MA Inc.
|
N/A
|
|
-29K
|
$8.60
|
-$248.40K
|
|
SEC
|
Willoughby Scott B.
|
SVP, Gen. Counsel & Secretary
|
|
-140
|
$8.12
|
-$1.14K
|
|
SEC
|
Duraibabu Prathyusha
|
VP, PFO and PAO
|
|
-345
|
$12.27
|
-$4.23K
|
|
SEC
|
LOEB GARY
|
EVP, General Counsel & Sec.
|
|
-5.5K
|
$12.27
|
-$68.01K
|
|
SEC
|
Macrae Sandy
|
President and CEO
|
|
-4K
|
$14.95
|
-$59.46K
|
|
SEC
|
Ramelmeier Rolf Andrew
|
EVP, Technical Operations
|
|
-2.5K
|
$16.74
|
-$41.25K
|
|
SEC
|
Ramelmeier Rolf Andrew
|
EVP, Technical Operations
|
|
-3.3K
|
$18.13
|
-$60.39K
|
|
SEC
|
Lee Sung
|
EVP, Chief Financial Officer
|
|
-5K
|
$9.77
|
-$49.26K
|
|
SEC
|
Duraibabu Prathyusha
|
VP Principal Acct. Officer
|
|
-647
|
$8.32
|
-$5.38K
|
|
SEC
|
PARKER H STEWART
|
N/A
|
|
+3K
|
$5.20
|
+$15.60K
|
|
SEC
|
Zakrzewski Joseph S
|
N/A
|
|
+5K
|
$4.99
|
+$24.95K
|
|
SEC
|
Zakrzewski Joseph S
|
N/A
|
|
+20K
|
$6.15
|
+$123.00K
|
|
SEC
|
Boissel Stephane
|
EVP, Corp. Strategy
|
|
+53K
|
$0.28
|
+$14.73K
|
|
SEC
|
Macrae Sandy
|
President and CEO
|
|
+161K
|
$0.28
|
+$45.22K
|
|
SEC
|
Ramelmeier Rolf Andrew
|
EVP, Technical Operations
|
|
+53K
|
$0.20
|
+$10.66K
|
|
SEC
|
Macrae Sandy
|
President and CEO
|
|
-4.3K
|
$7.50
|
-$32.12K
|
|
SEC
|
Conner Edward R.
|
Sr. VP & Chief Medical Officer
|
|
-834
|
$11.10
|
-$9.26K
|
|
SEC
|
Yi Kathy
|
SVP & Chief Financial Officer
|
|
-988
|
$11.10
|
-$10.97K
|
|
SEC
|
PARKER H STEWART
|
N/A
|
|
+2K
|
$9.00
|
+$18.00K
|
|
SEC
|
JEFFS ROGER
|
N/A
|
|
+7.4K
|
$13.56
|
+$100.45K
|
|
SEC
|
PARKER H STEWART
|
N/A
|
|
+2K
|
$13.52
|
+$27.04K
|
|
SEC
|
Yi Kathy
|
SVP & Chief Financial Officer
|
|
-5K
|
$15.67
|
-$78.35K
|
|
SEC
|
Mento Steven J
|
N/A
|
|
+2.8K
|
$12.23
|
+$34.06K
|
|
SEC
|
Mento Steven J
|
N/A
|
|
+5.6K
|
$12.36
|
+$68.81K
|
|
SEC
|
Mento Steven J
|
N/A
|
|
+3.5K
|
$13.99
|
+$48.69K
|
|
SEC
|
Herberts Curt A. III
|
Sr.VP & Chief Business Officer
|
|
-6K
|
$15.21
|
-$91.00K
|
|
SEC
|
Herberts Curt A. III
|
Sr.VP & Chief Business Officer
|
|
-3.6K
|
$16.53
|
-$59.51K
|
|
SEC
|
Herberts Curt A. III
|
Sr.VP & Chief Business Officer
|
|
-2K
|
$12.98
|
-$25.96K
|
|
SEC
|
Herberts Curt A. III
|
Sr.VP & Chief Business Officer
|
|
-4.7K
|
$11.09
|
-$51.95K
|
|
SEC
|
Herberts Curt A. III
|
Sr.VP & Chief Business Officer
|
|
-15K
|
$9.93
|
-$147.24K
|
|
SEC
|
Herberts Curt A. III
|
Senior VP & CBO
|
|
-2K
|
$6.80
|
-$13.60K
|
|
SEC
|
Herberts Curt A. III
|
Senior VP & CBO
|
|
-2.6K
|
$8.02
|
-$21.16K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$10.43
|
-$260.75K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$11.08
|
-$277.00K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-12K
|
$12.21
|
-$146.52K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$12.29
|
-$184.35K
|
|
SEC
|
RINGO WILLIAM R
|
N/A
|
|
-2.2K
|
$12.44
|
-$27.37K
|
|
SEC
|
Gregory Philip D
|
SVP of Research & CSO
|
|
-15K
|
$12.39
|
-$185.85K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$11.51
|
-$287.75K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-12K
|
$13.25
|
-$159.00K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$12.29
|
-$184.35K
|
|
SEC
|
RINGO WILLIAM R
|
N/A
|
|
-3K
|
$12.98
|
-$38.94K
|
|
SEC
|
Gregory Philip D
|
SVP of Research & CSO
|
|
-15K
|
$12.62
|
-$189.30K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$15.33
|
-$383.25K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-12K
|
$15.31
|
-$183.72K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$14.94
|
-$224.10K
|
|
SEC
|
RINGO WILLIAM R
|
N/A
|
|
-2.2K
|
$14.95
|
-$32.89K
|
|
SEC
|
Gregory Philip D
|
SVP of Research & CSO
|
|
-15K
|
$15.15
|
-$227.25K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-10K
|
$18.00
|
-$180.00K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$17.29
|
-$432.25K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-12K
|
$16.68
|
-$200.16K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$18.29
|
-$274.35K
|
|
SEC
|
Mento Steven J
|
N/A
|
|
-6.5K
|
$18.30
|
-$118.97K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-10K
|
$18.00
|
-$180.00K
|
|
SEC
|
RINGO WILLIAM R
|
N/A
|
|
-2.2K
|
$17.21
|
-$37.86K
|
|
SEC
|
Gregory Philip D
|
SVP of Research & CSO
|
|
-15K
|
$17.26
|
-$258.90K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$15.69
|
-$392.25K
|
|
SEC
|
Ramasastry Saira
|
N/A
|
|
-10K
|
$15.00
|
-$150.00K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-12K
|
$12.65
|
-$151.80K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$12.93
|
-$193.95K
|
|
SEC
|
RINGO WILLIAM R
|
N/A
|
|
-2.2K
|
$12.70
|
-$27.94K
|
|
SEC
|
Gregory Philip D
|
SVP of Research & CSO
|
|
-15K
|
$12.86
|
-$192.90K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$14.22
|
-$355.50K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-12K
|
$15.87
|
-$190.44K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$15.19
|
-$227.85K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-15K
|
$15.10
|
-$226.50K
|
|
SEC
|
RINGO WILLIAM R
|
N/A
|
|
-2.2K
|
$15.20
|
-$33.44K
|
|
SEC
|
Gregory Philip D
|
SVP, Research & CSO
|
|
-15K
|
$15.78
|
-$236.70K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$15.40
|
-$385.00K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-10K
|
$16.28
|
-$162.80K
|
|
SEC
|
Mento Steven J
|
N/A
|
|
-6.4K
|
$15.00
|
-$95.31K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-10K
|
$12.00
|
-$120.00K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$11.21
|
-$168.15K
|
|
SEC
|
Gregory Philip D
|
SVP of Research & CSO
|
|
-15K
|
$11.68
|
-$175.20K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$11.23
|
-$280.75K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-10K
|
$12.00
|
-$120.00K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-2K
|
$11.37
|
-$22.74K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$11.35
|
-$170.25K
|
|
SEC
|
Gregory Philip D
|
SVP of Research & CSO
|
|
-15K
|
$11.91
|
-$178.65K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-10K
|
$12.02
|
-$120.20K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$10.49
|
-$262.25K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-2K
|
$10.10
|
-$20.20K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$10.72
|
-$160.80K
|
|
SEC
|
Gregory Philip D
|
SVP of Research & CSO
|
|
-15K
|
$10.80
|
-$162.00K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$12.14
|
-$303.50K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-2K
|
$12.31
|
-$24.62K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$12.20
|
-$183.00K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-10K
|
$12.81
|
-$128.10K
|
|
SEC
|
Gregory Philip D
|
SVP of Research & CSO
|
|
-15K
|
$13.45
|
-$201.75K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$13.95
|
-$348.75K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-10K
|
$14.17
|
-$141.70K
|
|
SEC
|
Ramasastry Saira
|
N/A
|
|
-10K
|
$14.00
|
-$140.00K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$12.99
|
-$194.85K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-10K
|
$12.56
|
-$125.60K
|
|
SEC
|
Gregory Philip D
|
SVP of Research & CSO
|
|
-15K
|
$12.54
|
-$188.10K
|
|
SEC
|
Kolchinsky Peter
|
N/A
|
|
-1M
|
$14.28
|
-$14.28M
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$12.16
|
-$304.00K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-15K
|
$13.26
|
-$198.90K
|
|
SEC
|
Gregory Philip D
|
SVP of Research & CSO
|
|
-15K
|
$15.66
|
-$234.90K
|
|
SEC
|
Ramasastry Saira
|
N/A
|
|
-5.6K
|
$15.53
|
-$86.19K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$16.41
|
-$410.25K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-15K
|
$15.62
|
-$234.30K
|
|
SEC
|
Mento Steven J
|
N/A
|
|
-4.3K
|
$15.00
|
-$64.92K
|
|
SEC
|
Kolchinsky Peter
|
N/A
|
|
-2M
|
$13.16
|
-$26.23M
|
|
SEC
|
Gregory Philip D
|
SVP of Research & CSO
|
|
-15K
|
$12.85
|
-$192.75K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$13.57
|
-$203.55K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$13.14
|
-$328.50K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-15K
|
$12.85
|
-$192.75K
|
|
SEC
|
Kolchinsky Peter
|
N/A
|
|
+755K
|
$14.78
|
+$11.16M
|
|
SEC
|
Gregory Philip D
|
SVP of Research & CSO
|
|
-15K
|
$13.68
|
-$205.20K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
+15K
|
$13.64
|
+$204.60K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-10K
|
$13.48
|
-$134.80K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$14.20
|
-$355.00K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-15K
|
$15.72
|
-$235.80K
|
|
SEC
|
Gregory Philip D
|
Sr. VP Res. & CSO
|
|
-15K
|
$17.80
|
-$267.00K
|
|
SEC
|
Kolchinsky Peter
|
N/A
|
|
+594K
|
$20.22
|
+$12.00M
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$18.65
|
-$279.75K
|
|
SEC
|
Gregory Philip D
|
See Remarks
|
|
-15K
|
$22.38
|
-$335.70K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-50K
|
$23.22
|
-$1.16M
|
|
SEC
|
Ramasastry Saira
|
N/A
|
|
-10K
|
$23.26
|
-$232.60K
|
|
SEC
|
Mento Steven J
|
N/A
|
|
-6.1K
|
$22.77
|
-$138.97K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-10K
|
$22.31
|
-$223.10K
|
|
SEC
|
Kolchinsky Peter
|
N/A
|
|
-209K
|
$20.61
|
-$4.32M
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$19.72
|
-$295.80K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-50K
|
$18.09
|
-$904.50K
|
|
SEC
|
RINGO WILLIAM R
|
N/A
|
|
-25K
|
$18.06
|
-$451.50K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-10K
|
$19.26
|
-$192.60K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research & CSO
|
|
-15K
|
$18.83
|
-$282.45K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$18.58
|
-$278.70K
|
|
SEC
|
Cleveland Paul B
|
N/A
|
|
-8.3K
|
$18.68
|
-$155.66K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-50K
|
$18.51
|
-$925.50K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-10K
|
$18.69
|
-$186.90K
|
|
SEC
|
Kolchinsky Peter
|
N/A
|
|
-58K
|
$17.30
|
-$999.94K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research & CSO
|
|
-15K
|
$13.56
|
-$203.40K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$14.37
|
-$215.55K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-50K
|
$12.47
|
-$623.50K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-10K
|
$11.97
|
-$119.70K
|
|
SEC
|
Cleveland Paul B
|
N/A
|
|
-10K
|
$11.64
|
-$116.40K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research & CSO
|
|
-15K
|
$11.66
|
-$174.90K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$11.83
|
-$177.45K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$10.11
|
-$252.75K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-10K
|
$10.00
|
-$100.00K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research & CSO
|
|
-15K
|
$9.60
|
-$144.00K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$10.39
|
-$155.85K
|
|
SEC
|
Cleveland Paul B
|
N/A
|
|
-10K
|
$10.93
|
-$109.30K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$11.32
|
-$283.00K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-10K
|
$11.28
|
-$112.80K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research & CSO
|
|
-15K
|
$10.54
|
-$158.10K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$11.29
|
-$282.25K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-10K
|
$10.86
|
-$108.60K
|
|
SEC
|
Cleveland Paul B
|
N/A
|
|
-7.3K
|
$10.30
|
-$74.96K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research & CSO
|
|
-15K
|
$10.33
|
-$154.95K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$10.04
|
-$150.60K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$10.12
|
-$253.00K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-10K
|
$10.00
|
-$100.00K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research & CSO
|
|
-15K
|
$9.89
|
-$148.35K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research & CSO
|
|
-15K
|
$10.04
|
-$150.60K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$10.09
|
-$151.35K
|
|
SEC
|
Kolchinsky Peter
|
N/A
|
|
-798K
|
$9.78
|
-$7.81M
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$10.00
|
-$250.00K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-10K
|
$10.00
|
-$100.00K
|
|
SEC
|
Cleveland Paul B
|
N/A
|
|
-8K
|
$9.59
|
-$76.72K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research & CSO
|
|
-3K
|
$7.88
|
-$23.64K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$8.32
|
-$124.80K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research & CSO
|
|
-6K
|
$10.09
|
-$60.54K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$10.72
|
-$160.80K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-5.2K
|
$10.00
|
-$51.90K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-10K
|
$10.00
|
-$100.00K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research & CSO
|
|
-6K
|
$9.54
|
-$57.24K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$9.18
|
-$137.70K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research & CSO
|
|
-6K
|
$10.00
|
-$60.00K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$10.00
|
-$250.00K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-10K
|
$10.00
|
-$100.00K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$8.64
|
-$129.60K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research & CSO
|
|
-6K
|
$9.53
|
-$57.18K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-8.6K
|
$10.00
|
-$86.00K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
-10K
|
$10.00
|
-$100.00K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research & CSO
|
|
-6K
|
$6.05
|
-$36.30K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-17K
|
$5.92
|
-$100.64K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-15K
|
$5.64
|
-$84.60K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-20K
|
$5.53
|
-$109.14K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-15K
|
$5.52
|
-$82.80K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-20K
|
$5.70
|
-$114.00K
|
|
SEC
|
Gregory Philip D
|
VP, Therapeutic Dev. & CMO
|
|
-6K
|
$6.00
|
-$36.00K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-5K
|
$5.66
|
-$28.30K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-15K
|
$6.20
|
-$93.00K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$5.60
|
-$84.00K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-15K
|
$5.30
|
-$79.50K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-5K
|
$5.18
|
-$25.90K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-15K
|
$5.25
|
-$78.75K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-20K
|
$5.47
|
-$109.40K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-15K
|
$5.24
|
-$78.60K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-15K
|
$5.00
|
-$75.00K
|
|
SEC
|
ANDO DALE G
|
VP, Therapeutic Dev. & CMO
|
|
-15K
|
$9.68
|
-$145.20K
|
|
SEC
|
Gregory Philip D
|
CSO & Vice President, Research
|
|
-2.5K
|
$6.00
|
-$15.00K
|
|
SEC
|
Ichikawa David G
|
Senior VP, Bus. Dev.
|
|
-4K
|
$6.47
|
-$25.88K
|
|
SEC
|
Gregory Philip D
|
CSO & Vice President, Research
|
|
-15K
|
$6.00
|
-$90.00K
|
|
SEC
|
Ichikawa David G
|
Senior VP, Bus. Dev.
|
|
-4K
|
$6.52
|
-$26.08K
|
|
SEC
|
Gregory Philip D
|
CSO & Vice President, Research
|
|
-15K
|
$6.80
|
-$102.00K
|
|
SEC
|
Ichikawa David G
|
Senior VP, Bus. Dev.
|
|
-4K
|
$6.74
|
-$26.96K
|
|
SEC
|
Gregory Philip D
|
CSO & Vice President, Research
|
|
-15K
|
$7.33
|
-$109.95K
|
|
SEC
|
Gregory Philip D
|
CSO & Vice President, Research
|
|
-19K
|
$7.54
|
-$146.52K
|
|
SEC
|
Ichikawa David G
|
Senior VP, Bus. Dev.
|
|
-8K
|
$7.70
|
-$61.60K
|
|
SEC
|
Gregory Philip D
|
CSO & Vice President, Research
|
|
-5K
|
$8.64
|
-$43.20K
|
|
SEC
|
Cleveland Paul B
|
N/A
|
|
-1.4K
|
$9.00
|
-$12.49K
|
|
SEC
|
Gregory Philip D
|
CSO & Vice President, Research
|
|
-2.5K
|
$7.97
|
-$19.93K
|
|
SEC
|
Gregory Philip D
|
CSO & Vice President, Research
|
|
-2.5K
|
$6.80
|
-$17.00K
|
|
SEC
|
Cleveland Paul B
|
N/A
|
|
-32K
|
$7.00
|
-$224.26K
|
|
SEC
|
Cleveland Paul B
|
N/A
|
|
-11K
|
$7.00
|
-$79.08K
|
|
SEC
|
Gregory Philip D
|
CSO & Vice President, Research
|
|
-2.5K
|
$6.00
|
-$15.00K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
+10K
|
$3.01
|
+$30.10K
|
|
SEC
|
Wolff Henry Ward
|
Exec VP & CFO
|
|
+9K
|
$3.00
|
+$27.00K
|
|
SEC
|
Gregory Philip D
|
CSO & Vice President, Research
|
|
-2.5K
|
$6.27
|
-$15.67K
|
|
SEC
|
Gregory Philip D
|
CSO & Vice President, Research
|
|
-2.5K
|
$6.15
|
-$15.38K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research
|
|
-1K
|
$10.12
|
-$10.12K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research
|
|
-10K
|
$10.62
|
-$106.20K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$10.61
|
-$265.25K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research
|
|
-1K
|
$10.85
|
-$10.85K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-5.7K
|
$11.02
|
-$62.81K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-23K
|
$11.20
|
-$252.00K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research
|
|
-1K
|
$10.01
|
-$10.01K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$10.07
|
-$251.75K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research
|
|
-1K
|
$10.71
|
-$10.71K
|
|
SEC
|
Ichikawa David G
|
Senior VP, Bus. Dev.
|
|
-15K
|
$13.36
|
-$200.40K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$13.37
|
-$334.25K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research
|
|
-1K
|
$12.69
|
-$12.69K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$11.44
|
-$286.00K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research
|
|
-1K
|
$10.20
|
-$10.20K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research
|
|
-1K
|
$10.01
|
-$10.01K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$8.87
|
-$221.75K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-75K
|
$12.60
|
-$945.00K
|
|
SEC
|
Ichikawa David G
|
Senior VP, Bus. Dev.
|
|
-15K
|
$12.05
|
-$180.75K
|
|
SEC
|
ZANTE GREG
|
VP, Finance & Administration
|
|
-5.1K
|
$12.00
|
-$61.20K
|
|
SEC
|
Ichikawa David G
|
Senior VP, Bus. Dev.
|
|
-15K
|
$12.97
|
-$194.55K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & Chief Exec Officer
|
|
-25K
|
$13.13
|
-$328.25K
|
|
SEC
|
ZANTE GREG
|
Vice President, Fin. & Admin.
|
|
-5K
|
$12.87
|
-$64.35K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & Chief Exec Officer
|
|
-25K
|
$13.13
|
-$328.25K
|
|
SEC
|
ZANTE GREG
|
Vice President, Fin. & Admin.
|
|
-5K
|
$15.80
|
-$79.00K
|
|
SEC
|
GERBER WILLIAM G
|
N/A
|
|
-6.1K
|
$16.00
|
-$97.60K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research
|
|
-5K
|
$16.00
|
-$80.00K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$14.86
|
-$371.50K
|
|
SEC
|
Mento Steven J
|
N/A
|
|
-15K
|
$14.75
|
-$221.25K
|
|
SEC
|
Mento Steven J
|
N/A
|
|
-20K
|
$14.85
|
-$289.58K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research
|
|
-25K
|
$17.58
|
-$439.50K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-10K
|
$18.93
|
-$189.30K
|
|
SEC
|
ZANTE GREG
|
Vice President, Fin. & Admin.
|
|
-13K
|
$18.03
|
-$225.38K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$16.15
|
-$403.75K
|
|
SEC
|
GERBER WILLIAM G
|
N/A
|
|
-5K
|
$13.34
|
-$66.70K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$12.09
|
-$302.25K
|
|
SEC
|
GERBER WILLIAM G
|
N/A
|
|
-5K
|
$10.87
|
-$54.35K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$10.01
|
-$250.25K
|
|
SEC
|
GERBER WILLIAM G
|
N/A
|
|
-5K
|
$9.66
|
-$48.30K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$10.05
|
-$251.25K
|
|
SEC
|
GERBER WILLIAM G
|
N/A
|
|
-5K
|
$8.50
|
-$42.50K
|
|
SEC
|
GERBER WILLIAM G
|
N/A
|
|
-5K
|
$8.00
|
-$40.00K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$7.32
|
-$183.00K
|
|
SEC
|
Kopp LeRoy C
|
N/A
|
|
+277K
|
$9.02
|
+$2.50M
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres and Chief Ex Officer
|
|
-25K
|
$6.79
|
-$169.75K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$6.92
|
-$173.00K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$6.67
|
-$166.75K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$8.00
|
-$200.00K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research
|
|
-8K
|
$8.18
|
-$65.44K
|
|
SEC
|
Kopp LeRoy C
|
N/A
|
|
+650K
|
$5.61
|
+$3.65M
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$6.38
|
-$159.50K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$6.52
|
-$163.00K
|
|
SEC
|
ZANTE GREG
|
VP, Finance & Administration
|
|
-40K
|
$7.02
|
-$280.22K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$5.43
|
-$135.75K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$5.45
|
-$136.25K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$5.90
|
-$147.50K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-25K
|
$5.46
|
-$136.50K
|
|
SEC
|
Gregory Philip D
|
Vice President, Research
|
|
-6K
|
$7.43
|
-$44.58K
|
|
SEC
|
ZANTE GREG
|
Sr. Director Finance & Admin
|
|
-8K
|
$7.90
|
-$63.20K
|
|
SEC
|
LANPHIER EDWARD O II
|
President & CEO
|
|
-25K
|
$5.41
|
-$135.25K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$5.15
|
-$15.45K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$5.17
|
-$15.51K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$5.37
|
-$16.11K
|
|
SEC
|
LANPHIER EDWARD O II
|
President and CEO
|
|
-20K
|
$5.41
|
-$108.20K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$5.34
|
-$16.02K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$5.07
|
-$15.21K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$5.31
|
-$15.93K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$5.45
|
-$16.35K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$5.51
|
-$16.53K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$5.80
|
-$17.40K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$5.52
|
-$16.56K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$5.26
|
-$15.78K
|
|
SEC
|
LANPHIER EDWARD O II
|
President and CEO
|
|
-9.2K
|
$5.01
|
-$45.84K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-6K
|
$5.03
|
-$30.18K
|
|
SEC
|
ZANTE GREG
|
Sr Dir., Finance & Admin
|
|
-5.4K
|
$5.05
|
-$27.35K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-1K
|
$5.30
|
-$5.30K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$5.04
|
-$15.12K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.00
|
-$2.50K
|
|
SEC
|
LANPHIER EDWARD O II
|
President and CEO
|
|
-7.6K
|
$5.10
|
-$38.76K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.15
|
-$2.58K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$5.36
|
-$16.08K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.56
|
-$2.78K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.50
|
-$2.75K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$5.65
|
-$16.95K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$5.90
|
-$17.70K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.64
|
-$2.82K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$5.90
|
-$17.70K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.80
|
-$2.90K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$5.81
|
-$17.43K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.41
|
-$2.71K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$6.24
|
-$18.72K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$6.17
|
-$3.09K
|
|
SEC
|
LARSON JOHN WILLIAM
|
N/A
|
|
-3K
|
$6.06
|
-$18.18K
|
|
SEC
|
LANPHIER EDWARD O II
|
President and CEO
|
|
-18K
|
$6.03
|
-$108.54K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.95
|
-$2.98K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.65
|
-$2.83K
|
|
SEC
|
LANPHIER EDWARD O II
|
Pres & Chief Ex Officer
|
|
-20K
|
$6.17
|
-$123.40K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.95
|
-$2.98K
|
|
SEC
|
BLUFORD PETER
|
N/A
|
|
-500
|
$6.12
|
-$3.06K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$6.41
|
-$3.21K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$6.54
|
-$3.27K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.87
|
-$2.94K
|
|
SEC
|
BLUFORD PETER
|
V.P., Corporate Development
|
|
-500
|
$6.18
|
-$3.09K
|
|
SEC
|
BLUFORD PETER
|
V.P., Corporate Development
|
|
-500
|
$6.51
|
-$3.26K
|
|
SEC
|
LANPHIER EDWARD O II
|
President and CEO
|
|
-20K
|
$6.20
|
-$124.00K
|
|
SEC
|
BLUFORD PETER
|
V.P., Corporate Development
|
|
-500
|
$5.67
|
-$2.84K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.71
|
-$2.86K
|
|
SEC
|
LANPHIER EDWARD O II
|
President and CEO
|
|
-20K
|
$6.05
|
-$121.00K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$6.21
|
-$3.11K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Finance
|
|
-500
|
$6.57
|
-$3.29K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.53
|
-$2.77K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.91
|
-$2.96K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$6.26
|
-$3.13K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.56
|
-$2.78K
|
|
SEC
|
LANPHIER EDWARD O II
|
President and CEO
|
|
-20K
|
$5.90
|
-$118.00K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.92
|
-$2.96K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$6.74
|
-$3.37K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$7.17
|
-$3.59K
|
|
SEC
|
LANPHIER EDWARD O II
|
President and CEO
|
|
-20K
|
$7.29
|
-$145.80K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-1K
|
$7.50
|
-$7.50K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$6.15
|
-$3.08K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.34
|
-$2.67K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.10
|
-$2.55K
|
|
SEC
|
BLUFORD PETER
|
N/A
|
|
-500
|
$5.00
|
-$2.50K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.00
|
-$2.50K
|
|
SEC
|
LANPHIER EDWARD O II
|
President and CEO
|
|
-7K
|
$5.00
|
-$35.00K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-300
|
$5.00
|
-$1.50K
|
|
SEC
|
BLUFORD PETER
|
VP, Corporate Development
|
|
-500
|
$5.00
|
-$2.50K
|
|
SEC
|
BLUFORD PETER
|
Vice President
|
|
-500
|
$5.05
|
-$2.53K
|
|
SEC
|
BLUFORD PETER
|
V.P., Corporate Development
|
|
-500
|
$5.00
|
-$2.50K
|
|
SEC
|
BLUFORD PETER
|
V.P., Corporate Development
|
|
-500
|
$5.09
|
-$2.55K
|
|
SEC
|
BLUFORD PETER
|
V.P., Corporate Development
|
|
-1K
|
$5.09
|
-$5.09K
|
|
SEC
|
Kopp LeRoy C
|
N/A
|
|
+85K
|
$19.28
|
+$1.64M
|
|